OpenAI and Los Alamos National Laboratory announce research partnership

OpenAI and Los Alamos National Laboratory (LANL) – one of the United States’ leading national laboratories – are working together to study how artificial intelligence can be used safely by scientists in laboratory settings to advance bioscientific research. This partnership follows a long tradition of the U.S. public sector, and in particular the national labs, working with the U.S. private sector to ensure advances in innovation translate to advancements in essential areas like health care and bioscience. 

The recent White House Executive Order on the Safe, Secure, and Trustworthy Development and Use of Artificial Intelligence⁠(opens in a new window) tasks the U.S. Department of Energy’s national labs to help evaluate the capabilities of frontier AI models, including biological capabilities. This is important to OpenAI because we believe AI has the potential to multiply the speed and impact of science for good. Already, Moderna is leveraging OpenAI’s technology to augment clinical trial development⁠ by building a data-analysis assistant designed to help analyze large data sets. Color Health⁠ built a new copilot using GPT‑4o to assist healthcare providers to make evidence-based decisions about cancer screening and treatment. 

“As a private company dedicated to serving the public interest, we’re thrilled to announce a first-of-its-kind partnership with Los Alamos National Laboratory to study bioscience capabilities,” said Mira Murati, OpenAI’s Chief Technology Officer. “This partnership marks a natural progression in our mission, advancing scientific research, while also understanding and mitigating risks.”

These new evaluations extend our previous work in several new dimensions: